Pulmoner Nodül Yönetimi
Özet
Bilgisayarlı tomografi kullanımının artmasıyla insidental pulmoner nodül saptama sıklığı yükselmiştir. Fleischner Derneği'ne göre pulmoner nodül, normal akciğer parankimi ile çevrili, 3 cm'den küçük, yaklaşık yuvarlak opasitelerdir. Nodüller solid, buzlu cam ve part-solid olmak üzere üç radyolojik kategoride sınıflandırılır. Tespit sonrası temel hedef, nodülü benign, şüpheli veya malign olarak karakterize etmektir. Malignite riski değerlendirilirken hastanın yaşı, sigara öyküsü, aile hikayesi ve mesleki kanserojen maruziyeti gibi klinik faktörler büyük önem taşır. Radyolojik olarak ise nodülün boyutu, hacimsel büyüme hızı, morfolojisi ve üst lob yerleşimi gibi kriterler incelenir. Perifissüral yerleşim, santral veya popcorn kalsifikasyonlar ile yağ dansitesi genellikle benign antitelere işaret ederken; spiküle kontur, plevral çekinti ve solid komponent gelişimi malignite şüphesini artırır. Yönetim sürecinde, risk faktörlerine göre yapılandırılmış Fleischner Derneği kılavuz algoritması takip edilerek takip BT aralıkları, PET/BT, ince iğne aspirasyon biyopsisi veya cerrahi eksizyon gibi seçenekler uygulanır. Bu multidisipliner yönetim, benign lezyonlarda gereksiz invaziv işlemleri önlerken, erken evre akciğer kanserlerinin yakalanmasını amaçlar.
With the widespread use of computed tomography, the detection rate of incidental pulmonary nodules has significantly increased. According to the Fleischner Society, a pulmonary nodule is defined as a well-circumscribed, approximately round opacity measuring less than 3 cm in diameter. Nodules are classified into three types based on their radiological attenuation: solid, ground-glass, and part-solid nodules. The primary step after detection is to characterize the nodule as benign, indeterminate, or malignant. Evaluation of malignancy risk incorporates patient age, smoking habits, family history, and occupational carcinogen exposure. Radiation features, including size, volumetric growth rate, margins, and upper lobe location, are also critical parameters. While perifissural location, central or popcorn calcifications, and fat attenuation typically suggest benign etiologies, features like spiculation, pleural retraction, and the development of solid components elevate malignancy suspicion. Nodule management involves clinical algorithms published by the Fleischner Society, utilizing serial CT surveillance, PET/CT, fine-needle aspiration biopsy, or surgical excision. This structured strategy aims to minimize unnecessary invasive diagnostic tests for benign diseases while ensuring the early diagnosis of lung cancer.
Referanslar
Hansell DM, Bankier AA, MacMahon H, et al. Fleischner Society: Glossary of terms for thoracic imaging. Radiology. 2008; 246: 697 –722. doi: 10.1148/radiol.2462070712.
Ost D, Fein AM, Feinsilver SH. Clinical practice. The solitary pulmonary nodule. N Engl J Med. 2003;348:2535–42. doi: 10.1191/1358863x04vm552xx.
Swensen SJ, Jett JR, Hartman TE, et al. Lung cancer screening with CT: Mayo Clinic experience. Radiology. 2003;226:756–61.doi: 10.1148/radiol.2263020036.
Gohagan J, Marcus P, Fagerstrom R, et al. Writing Committee, Lung Screening Study Research Group. Baseline findings of a randomized feasibility trial of lung cancer screening with spiral CT scan vs chest radiograph: the Lung Screening Study of the National Cancer Institute. Chest. 2004;12:114–21.doi: 10.1378/chest.126.1.114.
Henschke CI, Yankelevitz DF, Libby DM, et al. Survival of patients with stage I lung cancer detected on CT screening. N Engl J Med. 2006;355:1763–71.doi: 10.1056/NEJMoa060476.
Revel MP, Lefort C, Bissery A, et al. Pulmonary nodules: preliminary experience with three-dimensional evaluation. Radiology. 2004;231:459–66. doi: 10.1148/radiol.2312030241.
Wood DE, Kazerooni EA, Baum SL, et al. Lung cancer screening, version 3.2018, NCCN Clinical Practice Guidelines in Oncology. J Natl Compr Canc Netw. 2018;16:412–41. doi: 10.6004/jnccn.2018.0020.
Guyatt GH, Newhouse MT. Are active and passive smoking harmful? Determination causation. Chest. 1985;88:445–1. doi: 10.1378/chest.88.3.445.
Doll R, Hill AB. Smoking and carcinoma of the lung; preliminary report. Br Med J. 1950;2:739–48. doi: 10.1136/bmj.2.4682.739.
Flanders WD, Lally CA, Zhu BP, et al. Lung cancer mortality in relation to age, duration of smoking, and daily cigarette consumption: Results from cancer prevention study II. Cancer Res. 2003;63:6556–62.
Lee HW, Park SH, Weng MW, et al. E-cigarette smoke damages DNA and reduces repair activity in mouse lung, heart, and bladder as well as in human lung and bladder cells. Proc Natl Acad Sci U S A. 2018;115:E1560–9. doi: 10.1073/pnas.1718185115.
Gould MK, Ananth L, Barnett PG Veterans Affairs SNAP Cooperative Study Group. A clinical model to estimate the pretest probability of lung cancer in patients with solitary pulmonary nodules. Chest. 2007;131:383–8. doi: 10.1378/chest.06-1261.
Siegel RL, Miller KD, Jemal A. Cancer statistics, 2015. CA Cancer J Clin. 2015;65:5–29. doi: 10.3322/caac.21254.
Ngamwong Y, Tangamornsuksan W, Lohitnavy O, et al. Additive synergism between asbestos and smoking in lung cancer risk: A Systematic review and meta-analysis. PLoS One. 2015;10:e0135798. doi: 10.1371/journal.pone.0135798.
Liu Y, Steenland K, Rong Y, et al. Exposure-response analysis and risk assessment for lung cancer in relationship to silica exposure: A 44-year cohort study of 34,018 workers. Am J Epidemiol. 2013;178:1424–33. doi: 10.1093/aje/kwt139.
Johnson BE. Second lung cancers in patients after treatment for an initial lung cancer. J Natl Cancer Inst. 1998;90:1335–45. doi: 10.1097/JTO.0b013e3182582a79.
Surapaneni R, Singh P, Rajagopalan K, et al. Stage I lung cancer survivorship: Risk of second malignancies and need for individualized care plan. J Thorac Oncol. 2012;7:1252–6.
Milano MT, Peterson CR, Zhang H, et al. Second primary lung cancer after head and neck squamous cell cancer: Population-based study of risk factors. Head Neck. 2012;34:1782–8. doi: 10.1002/hed.22006.
Hoppe RT. Hodgkin's disease: Complications of therapy and excess mortality. Ann Oncol. 1997;8(Suppl 1):115–8.
Lorigan P, Radford J, Howell A, et al. Lung cancer after treatment for Hodgkin's lymphoma: A systematic review. Lancet Oncol. 2005;6:773–9. doi: 10.1016/S1470-2045(05)70387-9.
Pirani M, Marcheselli R, Marcheselli L, et al. Risk for second malignancies in non-Hodgkin's lymphoma survivors: A meta-analysis. Ann Oncol. 2011;22:1845–58. doi: 10.1093/annonc/mdq697.
Nitadori J, Inoue M, Iwasaki M, et al. Association between lung cancer incidence and family history of lung cancer: Data from a large-scale population-based cohort study, the JPHC study. Chest. 2006; 130 : 968 –75. doi: 10.1378/chest.130.4.968.
Wilson DO, Weissfeld JL, Balkan A, Schragin JG, et al. Association of radiographic emphysema and airflow obstruction with lung cancer. Am J Respir Crit Care Med. 2008;178:738–44. doi: 10.1164/rccm.200803-435OC.
Henschke CI, Yip R, Boffetta P, et al. CT screening for lung cancer: Importance of emphysema for never smokers and smokers. Lung Cancer. 2015; 88:42–7. doi: 10.1016/j.lungcan.2015.01.014
Raghu G, Amatto VC, Behr J, et al. Comorbidities in idiopathic pulmonary fibrosis patients: A systematic literature review. Eur Respir J. 2015;46:1113–30. doi: 10.1183/13993003.02316-2014.
Antoniou KM, Tomassetti S, Tsitoura E, et al. Idiopathic pulmonary fibrosis and lung cancer: A clinical and pathogenesis update. Curr Opin Pulm Med. 2015;21:626–33. doi: 10.1097/MCP.0000000000000217.
MacMahon H, Naidich DP, Goo JM, et al. Guidelines for management of incidental pulmonary nodules detected on CT images: From the Fleischner Society 2017. Radiology. 2017;284:228–43. doi: 10.1148/radiol.2017161659.
NCCN Clinical Practice Guidelines in Oncology (NCCN Guidelines®) Non-Small Cell Lung Cancer Version 2.2019. 2018. Nov 21, [Last accessed on 2018 Dec 12]. Available from: https://www.nccn.org/
Horeweg N, van Rosmalen J, Heuvelmans MA, et al. Lung cancer probability in patients with CT-detected pulmonary nodules: A prespecified analysis of data from the NELSON trial of low-dose CT screening. Lancet Oncol. 2014;15:1332–41. doi: 10.1016/S1470-2045(14)70389-4
Heuvelmans MA, Oudkerk M, de Bock GH, et al. Optimisation of volume-doubling time cutoff for fast-growing lung nodules in CT lung cancer screening reduces false-positive referrals. Eur Radiol 2013;23(7):1836–1845. doi: 10.1007/s00330-013-2799-9.
Mehta HJ, Ravenel JG, Shaftman SR, et al. The utility of nodule volume in the context of malignancy prediction for small pulmonary nodules. Chest 2014;145(3):464–472. doi: 10.1378/chest.13-0708.
De Hoop B, van Ginneken B, Gietema H, et al. Pulmonary perifissural nodules on CT scans: Rapid growth is not a predictor of malignancy. Radiology. 2012;265:611–6. doi: 10.1148/radiol.12112351.
Wang CW, Teng YH, Huang CC, et al. Intrapulmonary lymph nodes: Computed tomography findings with histopathologic correlations. Clin Imaging. 2013;37: 487–92. doi: 10.1016/j.clinimag.2012.09.010.
Ahn MI, Gleeson TG, Chan IH, et al. Perifissural nodules seen at CT screening for lung cancer. Radiology. 2010;254:949–56. doi: 10.1148/radiol.09090031.
Callister ME, Baldwin DR, Akram AR, et al. British Thoracic Society guidelines for the investigation and management of pulmonary nodules. Thorax. 2015;70(Suppl 2):ii1–54. doi: 10.1136/thoraxjnl-2015-207168.
Grewal RG, Austin JH. CT demonstration of calcification in carcinoma of the lung. J Comput Assist Tomogr. 1994;18:867–71. doi: 10.1097/00004728-199411000-00004.
Truong MT, Ko JP, Rossi SE , et al. Update in the evaluation of the solitary pulmonary nodule. Radiographics. 2014;34:1658–79. doi: 10.1148/rg.346130092.
McWilliams A, Tammemagi MC, Mayo JR, et al. Probability of cancer in pulmonary nodules detected on first screening CT. N Engl J Med. 2013;369:910–9. doi: 10.1056/NEJMoa1214726.
Swensen SJ, Silverstein MD, Ilstrup DM, et al. The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med. 1997;157:849–55.
Herold CJ, Bankier AA, Fleischmann D. Lung metastases. Eur Radiol. 1996;6:596–606. doi: 10.1007/BF00187656.
Lee KH, Goo JM, Park SJ, et al. Correlation between the size of the solid component on thin-section CT and the invasive component on pathology in small lung adenocarcinomas manifesting as ground-glass nodules. J Thorac Oncol. 2014;9:74–82. doi: 10.1097/JTO.0000000000000019.
Cohen JG, Reymond E, Lederlin M, et al. Differentiating pre – And minimally invasive from invasive adenocarcinoma using CT-features in persistent pulmonary part-solid nodules in caucasian patients. Eur J Radiol. 2015;84:738–44. doi: 10.1016/j.ejrad.2014.12.031.
Detterbeck FC, Homer RJ. Approach to the ground-glass nodule. Clin Chest Med. 2011;32:799–810. doi: 10.1016/j.ccm.2011.08.002.
Cho J, Ko SJ, Kim SJ, et al. Surgical resection of nodular ground-glass opacities without percutaneous needle aspiration or biopsy. BMC Cancer. 2014;14:838. doi.org/10.1186/1471-2407-14-838
